Sponsor

The First Affiliated Hospital of Nanchang University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name The First Affiliated Hospital of Nanchang University appears in 22 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials22
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

22 shown
Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)NCT05453721 · lead sponsor · 2022-08-04
COMPLETED
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal HypertensionNCT02543658 · lead sponsor · 2015-09-01
COMPLETED
Follow-up Study of Complications of Acute PancreatitisNCT02305914 · lead sponsor · 2014-11-01
UNKNOWN
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.NCT07019012 · collaborator · 2025-07-30
RECRUITING
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)NCT05598528 · collaborator · 2021-09-28
RECRUITING
Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical StudyNCT07854002 · collaborator · 2026-10-08
NOT_YET_RECRUITING
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive BleedingNCT07502729 · collaborator · 2026-03-17
NOT_YET_RECRUITING
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate CancerNCT06434649 · collaborator · 2025-11-01
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes MellitusNCT06494683 · collaborator · 2024-07-25
UNKNOWN
The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver CirrhosisNCT06470386 · collaborator · 2024-06-01
UNKNOWN
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsNCT06010862 · collaborator · 2023-09-30
UNKNOWN
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNCT05824923 · collaborator · 2023-08-14
ACTIVE_NOT_RECRUITING
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung CancerNCT05925738 · collaborator · 2023-05-01
UNKNOWN
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerNCT05925751 · collaborator · 2023-05-01
UNKNOWN
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell TherapyNCT05638776 · collaborator · 2022-12-06
COMPLETED
Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung AdenocarcinomaNCT05736991 · collaborator · 2022-11-01
UNKNOWN
Deep Learning Model for Pure Solid Nodules ClassificationNCT05542992 · collaborator · 2022-01-01
UNKNOWN
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung CancerNCT05425134 · collaborator · 2022-01-01
UNKNOWN
Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass OpacitiesNCT04982900 · collaborator · 2021-10-01
UNKNOWN
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in CirrhosisNCT04932200 · collaborator · 2021-06-15
UNKNOWN
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)NCT06524427 · collaborator · 2020-08-25
ACTIVE_NOT_RECRUITING
Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary NodulesNCT03651986 · collaborator · 2018-11-26
UNKNOWN

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing The First Affiliated Hospital of Nanchang University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo2
alverine1
carvedilol1
neostigmine methylsulfate 1 MG/ML1

Sponsor roles

collaborator19
lead sponsor3
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.